Advances in the treatment of plasma cell diseases.
Dose-intensive chemotherapy and marrow transplantation in myeloma achieve complete remission in many cases and may significantly prolong patient survival. Use of myeloid growth factors or mobilized blood stem cell preparations decreases morbidity and mortality from treatment. These approaches also show promise in AL amyloidosis.
Comenzo
R L
RL
Boston University School of Medicine, USA.
D000328:Adult; D000686:Amyloidosis / Q000175:diagnosis / Q000628:therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007074:Immunoglobulin G; D008297:Male; D009101:Multiple Myeloma / Q000175:diagnosis / Q000628:therapy*; D012074:Remission Induction; D016019:Survival Analysis; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D007074:Immunoglobulin G